Abstract
Executive Summary
People who suffer from urinary incontinence (UI) not only face embarrassment
but also go through a lot of pain and inconvenience it causes. UI leads to
frequent and unplanned trips to the lavatory and makes it inconvenient for the
people suffering from it, especially during the night time when they are
sleeping and incontinence occurs. The affected person experiences a strong
sense of urgency in UI, which produces a serious concern of being too far from
the facilities. Though incontinence is related to the normal bodily function,
it impacts the quality of life significantly as it affects sleep, energy
levels and social interactions.
UI affects both males and females and it has been noted that the possibility
of someone developing UI increases with growing age. In some case, UI affects
females after child birth or menopause. Despite of the mentioned observations,
UI has not yet been classified as a disease related to old age or a definite
outcome of childbirth in females.
Among the four established types of UI, stress incontinence is the most common
among females. Various options are available in the market for UI treatment,
which include surgical procedures, drugs and medications but the treatment is
to be chosen on the basis of the type of incontinence the patient is suffering
from.
The continence care products include devices, diapers, pads, and urisheaths.
The diapers and pads are being used just for maintenance of UI, while the
devices and drugs are used in the treatment of the same. Globally, people are
increasingly getting aware regarding UI and are slowly starting to overcome
the embarrassment as patients are moving away from just managing their problem
towards getting a permanent solution for UI.
This report gives an overview about the market of incontinence products,
concentrating specifically on the devices. It analyzes the market on a global
basis, in terms of industry growth, market share of players as well regional
market shares. The drivers and challenges of the market are also highlighted
in the report. Lastly, it profiles the leading market players.
Key Findings:
- The market for urinary continence care was estimated to be around US$1.8
billion in 2008, registering growth rate of around 7%.
- The expected growth rate of UI market is to be in the range of 6-8% till
2012 when the market would reach a forecasted value in the range of US$2.3-2.4
billion.
- Europe is the largest market with more than 50% market share.
- Coloplast is the market leader in urology and continence care market with
a 15% share of the market in 2006. Coloplast maintained a leading 34% market
share of global continence consumables in 2007/08.
- The market for MEC in 2007 was US$128 million, for IC it was US$390
million, while it was US$380 million for Foley catheters.
- Approximately 50 million men have incontinence and 450 million women
worldwide have urinary or fecal incontinence.
Table of Contents
1. Urinary Incontinence: An Overview
2. Market Size
3. Market by Segments
- 3.1 Market by Product Segments
- 3.1.1 Male External Catheters (MEC)
- 3.1.2 Intermittent Catheters (IC)
- 3.1.3 Foley Market
- 3.2 Male Continence Market
- 3.3 Female Continence Market
4. Market Dynamics
- 4.1 Market Drivers
- 4.1.1 New Medicare Policy reimbursement and re-use restriction
- 4.1.2 Under-penetrated intermittent catheters population
- 4.2 Market Challenges
- 4.2.1 Awareness and Embarrassment
- 4.2.2 Approach towards treating Incontinence
5. Company Profiles
- 5.1 Coloplast A/S
- 5.2 C. R. Bard
- 5.3 American Medical Systems Holdings
- 5.4 Boston Scientific Corp
6. Market Outlook
